Is cobalt-binding capacity of serum a new perspective diagnostic marker?

   
Litus E.A.1 , Zaitsev V.G.1, Verovskij V.E.1, Goncharova L.V.1, Dudchenko G.P.1, Ostrovskij O.V.1

1. Volgograd State Medical University
Section: Clinical Study
DOI: 10.18097/pbmc20146004487      UDK: 616-074:543.33:546.73-07.616.15-07      PubMed Id: 25249533
Year: 2014  Volume: 60  Issue: 4  Pages: 487-492
The aim of this study was to determine the reference interval of serum cobalt-binding capacity (CoBC) and to estimate the effect of factors unrelated to oxidative modification of serum albumin on this diagnostic marker. A group of healthy volunteers (n=194), a group of patients with autoimmune diseases (n=44) and a group of patients with diabetes type 2 (n=50) participated in this study. The regional reference interval was found to be 0,462-0,744 mmol Co 2+ /l of serum. The study of serum CoBC in two groups of patients showed that the CoBC level strongly depends on the serum protein profile. Therefore, this diagnostic test may be used for diagnosing ischemia, but other pathologies associated with changes in a ratio of blood protein fractions can also influence the serum CoBC level.
Download PDF:
Reference:

Litus E.A., Zaitsev V.G., Verovskij V.E., Goncharova L.V., Dudchenko G.P., Ostrovskij O.V. (2014) Biomeditsinskaya khimiya, 60(4), 487-492.
This paper is also available as the English translation:10.1134/S1990750813030086
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)
        

© Institute of Biomedical Chemistry, Moscow, Russia